title: Clinical and immunologic aspects of cytomegalovirus infection in solid organ transplant recipients.
abstract: Primary cytomegalovirus (CMV) infection is a major cause of morbidity and mortality in recipients after solid organ transplantation (SOT). Widespread and prolonged use of antiviral drugs has changed the natural course of CMV disease by delaying its onset and causing drug resistance. CMV induces a strong cellular immune response, even in immunosuppressed patients, and has developed strategies to evade this immune surveillance. This review summarizes challenges in managing CMV infection in transplant recipients and highlights current insights in the cellular immune response against CMV.
authors.affiliation: Department of Internal Medicine, Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, 1100 DE Amsterdam, the Netherlands. T.Rowshani@amc.uva.nl
authors.forename: Ajda T
authors.initials: AT
authors.lastname: Rowshani
authors.forename: Frederike J
authors.initials: FJ
authors.lastname: Bemelman
authors.forename: Ester M M
authors.initials: EM
authors.lastname: van Leeuwen
authors.forename: René A W
authors.initials: RA
authors.lastname: van Lier
authors.forename: Ineke J M
authors.initials: IJ
authors.lastname: ten Berge
mesh_terms: D003587:Cytomegalovirus / Q000276:immunology; D003586:Cytomegalovirus Infections / Q000175:diagnosis / Q000276:immunology / Q000628:therapy*; D006801:Humans; D016377:Organ Transplantation / Q000009:adverse effects*; D013601:T-Lymphocytes / Q000276:immunology; D014611:Vaccination; D014765:Viral Vaccines / Q000276:immunology
chemical_list: D014765:Viral Vaccines